These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7603652)

  • 61. Combination drugs..
    Gever MP
    Nursing; 2005 Aug; 35(8):76. PubMed ID: 16062159
    [No Abstract]   [Full Text] [Related]  

  • 62. UNDESIRABLE DRUG COMBINATIONS.
    MOORE JM
    Scott Med J; 1964 Jun; 9():268-9. PubMed ID: 14157415
    [No Abstract]   [Full Text] [Related]  

  • 63. [Palliative care: care in the final days].
    Benítez del Rosario MA; Pascual L; Asensio Fraile A
    Aten Primaria; 2002 Sep; 30(5):318-22. PubMed ID: 12372214
    [No Abstract]   [Full Text] [Related]  

  • 64. Opioid analgesics: comparative features and prescribing guidelines.
    Cherny NI
    Drugs; 1996 May; 51(5):713-37. PubMed ID: 8861543
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of tubing on loss of clonazepam administered by continuous subcutaneous infusion.
    Schneider JJ; Good P; Ravenscroft PJ
    J Pain Symptom Manage; 2006 Jun; 31(6):563-7. PubMed ID: 16793496
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The compatibility and stability of midazolam and dexamethasone in infusion solutions.
    Good PD; Schneider JJ; Ravenscroft PJ
    J Pain Symptom Manage; 2004 May; 27(5):471-5. PubMed ID: 15120775
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Drugs given by a syringe driver: a prospective multicentre survey of palliative care services in the UK.
    Wilcock A; Jacob JK; Charlesworth S; Harris E; Gibbs M; Allsop H
    Palliat Med; 2006 Oct; 20(7):661-4. PubMed ID: 17060264
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Incidence and causes for syringe driver site reactions in palliative care: A prospective hospice-based study.
    Mitchell K; Pickard J; Herbert A; Lightfoot J; Roberts D
    Palliat Med; 2012 Dec; 26(8):979-85. PubMed ID: 22084491
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Drug combinations in syringe drivers.
    Lichter I; Hunt E
    N Z Med J; 1995 Jun; 108(1001):224-6. PubMed ID: 7603652
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Adverse drug effects and their clinical importance within the scope of intensive care and emergency medicine].
    Borchard U
    Klin Wochenschr; 1991; 69 Suppl 26():20-3. PubMed ID: 1687602
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adverse drug interactions clinically important for the dermatologist.
    Andersen WK; Feingold DS
    Arch Dermatol; 1995 Apr; 131(4):468-73. PubMed ID: 7726592
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Continuous subcutaneous infusion in palliative care: a review of current practice.
    Thomas T; Barclay S
    Int J Palliat Nurs; 2015 Feb; 21(2):60, 62-4. PubMed ID: 25715160
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.